Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037387 | SCV000061044 | likely benign | not specified | 2013-01-23 | criteria provided, single submitter | clinical testing | Ala162Ala in exon 5 of LAMA4: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. Ala162Ala in exon 5 of LAMA4 (allele frequenc y = n/a) |
Ambry Genetics | RCV000617194 | SCV000736742 | likely benign | Cardiovascular phenotype | 2017-01-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769209 | SCV000900585 | benign | Cardiomyopathy | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000865924 | SCV001006952 | benign | Dilated cardiomyopathy 1JJ | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000037387 | SCV001918288 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727528 | SCV001969559 | likely benign | not provided | no assertion criteria provided | clinical testing |